VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension (SIL-REACT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Kerckhoff Heart Center
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Dr. Andreas Rieth, Kerckhoff Heart Center
ClinicalTrials.gov Identifier:
NCT01889966
First received: June 9, 2013
Last updated: June 26, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)